Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack...

FDA Drug Recall #D-1387-2020 — Class II — June 29, 2020

Recall Summary

Recall Number D-1387-2020
Classification Class II — Moderate risk
Date Initiated June 29, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm RemedyRepack Inc.
Location Indiana, PA
Product Type Drugs
Quantity 498 tablets

Product Description

Carbamazepine 200 mg Tablets, 100-unit dose tablets per box, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2489-00 for box; 70518-2489-01 per unit dose.

Reason for Recall

FAILED DISSOLUTION SPECIFICATION: Low out-of-specification (OOS) dissolution results obtained during routine stability testing.

Distribution Pattern

Product was distributed to MN.

Lot / Code Information

Lot #: B0796217-020920, Exp. Date: 02/28/2021

Other Recalls from RemedyRepack Inc.

Recall # Classification Product Date
D-0411-2025 Class II Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsul... Apr 22, 2025
D-0378-2025 Class II Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsul... Mar 24, 2025
D-0217-2025 Class II Carvedilol 25 mg Tablet, QTY: 30 Tablets per Bl... Jan 24, 2025
D-0165-2025 Class II Duloxetine Delayed-Release Capsules, 60 mg, a) ... Dec 2, 2024
D-0611-2024 Class II Potassium Chloride Micro 10mEq K (750 mg) Exten... Jun 26, 2024

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.